[Surface immonoglobulins and biological activity of the lymphocytes in bronchial asthma].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to T Moniuszko.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Broncho-vaxom was administered to 40 patients with recurrent respiratory infections, allergic-infectious bronchial asthma and chronic bronchitis. Broncho-vaxom was administered in the dose of one capsule for the first month, and 1 capsule for 10 days in the third, fourth, and fifth month. A favourable clinical effect has been achieved in over 50% of the treated patients manifested by the decrease in the number and severity of respiratory infections and reductions in antibiotics use. These results confirm clinical efficiency of this vaccine.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.